Organization
Acure Pharma AB
2 abstracts
Abstract
ANTAGONIZING THE 5-HT2 RECEPTORS REPRESENTS A NOVEL MECHANISM FOR SUPPRESSING INFLAMMATION IN ARTHRITIS Org: AnaMar AB, Lund, Acure Pharma AB,
Abstract
AMAP102, AN ORALLY AVAILABLE 5-HT2 RECEPTOR ANTAGONIST DEVELOPED FOR THE TREATMENT OF RA, IS SAFE AND WELL TOLERATED IN HEALTHY SUBJECTS Org: AnaMar AB, Lund, Acure Pharma AB, Dept. of Medicinal Chemistry, BMC, Uppsala, Sweden,